BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 2758842)

  • 21. Heterogeneous deoxyribonucleic acid-binding forms of rabbit uterine progesterone receptor.
    Lamb DJ; Bullock DW
    Endocrinology; 1984 May; 114(5):1833-40. PubMed ID: 6714169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Binding of (3H)7 alpha,17 alpha-dimethyl-19-nortestosterone (mibolerone) to progesterone receptors: comparison with binding of (3H)R5020 and (3H)ORG2058.
    Traish AM; Williams DF; Wotiz HH
    Steroids; 1986; 47(2-3):157-73. PubMed ID: 3564084
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Occurrence of common binding sites for progestin and glucocorticoid in the lactating mammary gland of the rat.
    Maki M; Hirose M; Chiba H
    J Biochem; 1980 Dec; 88(6):1845-54. PubMed ID: 7193205
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Effects of progestins on the progesterone receptor in guinea pig uterus.
    Saffran J; Loeser BK; Faber LE
    Adv Exp Med Biol; 1979; 117():223-39. PubMed ID: 474278
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Estrogen-sensitive progestin binding sites in the brain of the lizard, Anolis carolinensis.
    Tokarz RR; Crews D; McEwen BS
    Brain Res; 1981 Sep; 220(1):95-105. PubMed ID: 7196792
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Chick oviduct glucocorticosteroid receptor. Specific binding of the synthetic steroid RU 486 and immunological studies with antibodies to chick oviduct progesterone receptor.
    Groyer A; Le Bouc Y; Joab I; Radanyi C; Renoir JM; Robel P; Baulieu EE
    Eur J Biochem; 1985 Jun; 149(2):445-51. PubMed ID: 3996417
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Plasma concentrations and receptor binding of RU 486 and its metabolites in humans.
    Heikinheimo O; Kontula K; Croxatto H; Spitz I; Luukkainen T; Lähteenmäki P
    J Steroid Biochem; 1987 Feb; 26(2):279-84. PubMed ID: 3560943
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The relationship between affinity of progestins and antiprogestins for the progesterone receptor in breast cancer cells (ZR-PR-LT) and ability to down-regulate the receptor: evidence for heterospecific receptor modulation via the glucocorticoid receptor.
    van den Berg HW; Lynch M; Martin JH
    Eur J Cancer; 1993; 29A(12):1771-5. PubMed ID: 8398308
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Characterization of estrogen-induced progestin binding in cytosol of the R3327 prostatic carcinoma of the rat.
    Mobbs BG; Johnson IE
    J Steroid Biochem; 1985 Jan; 22(1):57-62. PubMed ID: 3871881
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Dihydrospirorenone (ZK30595): a novel synthetic progestagen--characterization of binding to different receptor proteins.
    Pollow K; Juchem M; Elger W; Jacobi N; Hoffmann G; Möbus V
    Contraception; 1992 Dec; 46(6):561-74. PubMed ID: 1493716
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Binding characteristics of progesterone and antiprogestin ZK 98.299 in human endometrial and myometrial cytosol.
    Puri CP; Hinduja IN; D'Souza A; Elger WA; Pongubala JM
    Biochim Biophys Acta; 1989 May; 1011(2-3):176-82. PubMed ID: 2713402
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of progesterone receptor binding in the ovine uterus.
    Bauer MA; Gorell TA
    Steroids; 1980 Nov; 36(5):581-91. PubMed ID: 7192894
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Nuclear progestin receptors in human uterus.
    Kasid A; Laumas KR
    Endocrinology; 1981 Aug; 109(2):553-60. PubMed ID: 7250058
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Characterization of a [3H]methyltrienolone (R1881) binding protein in rat liver cytosol.
    Levinson DJ; Decker DE
    J Steroid Biochem; 1985 Feb; 22(2):211-9. PubMed ID: 3872380
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Characterization of 7-8S progestin binding protein in human prostate using vertical tube rotor.
    Schneider SL; Pontes JE; Greco JM; Murphy GP; Sandberg AA
    J Steroid Biochem; 1984 Mar; 20(3):715-23. PubMed ID: 6538623
    [TBL] [Abstract][Full Text] [Related]  

  • 36. RU 38486: potent antiglucocorticoid activity correlated with strong binding to the cytosolic glucocorticoid receptor followed by an impaired activation.
    Moguilewsky M; Philibert D
    J Steroid Biochem; 1984 Jan; 20(1):271-6. PubMed ID: 6708512
    [TBL] [Abstract][Full Text] [Related]  

  • 37. RU 486 stabilizes a high molecular weight form of the glucocorticoid receptor containing the 90K non-steroid binding protein in intact thymus cells.
    Lefebvre P; Formstecher P; Richard C; Dautrevaux M
    Biochem Biophys Res Commun; 1988 Feb; 150(3):1221-9. PubMed ID: 3342067
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Binding of the anti-progestin RU-486 to rat ovary steroid receptors.
    Schreiber JR; Hsueh AJ; Baulieu EE
    Contraception; 1983 Jul; 28(1):77-85. PubMed ID: 6627946
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Evidence for separate binding sites for progesterone and RU486 in the chick oviduct.
    Moudgil VK; Lombardo G; Hurd C; Eliezer N; Agarwal MK
    Biochim Biophys Acta; 1986 Nov; 889(2):192-9. PubMed ID: 3778947
    [TBL] [Abstract][Full Text] [Related]  

  • 40. 3H-cyproterone acetate: binding characteristics to human uterine progestagen receptors.
    Grill HJ; Manz B; Elger W; Pollow K
    J Endocrinol Invest; 1985 Apr; 8(2):135-41. PubMed ID: 3161932
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.